Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers

Completed · Phase 1

Conditions studied: Juvenile Idiopathic Arthritis

In brief

This is an assessment of Pharmacokinetics of a single oral dose of VIMOVO in healthy adult volunteers.

Key facts

Study ID

NCT01358383

Run by

AstraZeneca

People needed

28

Starts

2011-05-01

Expected to finish

2011-06-01

Last updated by the study team

2012-06-22

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subjects aged 18 to 55 years
• Capable of understanding and complying with the Clinical Study Protocol
• Body mass index (BMI) of 19 to 30 kg/m2 and weight of 50 to 100 kg

You may not qualify if…

• Previous enrollment in the present study
• Receipt of another investigational product within 4 weeks before this study or plans to participate in another study at the same time as this study
• Female subjects with a positive urine pregnancy test

Where it is running

• Research Site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.